FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20220120E00231
1. Date of relevant event: 17/01/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01167
4. Name of listed corporation: Jacobio Pharmaceuticals Group Co., Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 771,462,180
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Hu
(Other names) Shaojing
10. Name of director (Chinese): 胡邵京 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1112The number of shares in which you are interested has increased because:
you became a member of a concert party group or a member of the concert party group acquired more of the shares
 
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
127,500  HKD  12.5900  12.5170   
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position271,122,97535.14
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position271,250,47535.16
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position41,290,000
2501Other (you must describe the capacity in the Supplementary Information box)
Long position229,960,475
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Emmanuelhupharma LtdCraigmuir Chambers, Road Town, Tortola VG1110, British Virgin IslandsShaojing Hu100.00Y
Long position41,290,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
Yinxiang WangAddresses of individuals are not displayed.
Long position271,250,475
Willgenpharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Yakovpharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Johwpharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Honourpharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Xiaojie WangAddresses of individuals are not displayed.
Long position271,250,475
Risepharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Gloryviewpharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Blesspharma LtdAddresses of individuals are not displayed.
Long position271,250,475
Yunyan HuAddresses of individuals are not displayed.
Long position271,250,475
Hmed LtdAddresses of individuals are not displayed.
Long position271,250,475
Wordspharma LtdAddresses of individuals are not displayed.
Long position271,250,475
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: 127,500 Shares was purchased by Yunyan Hu on public market. Box 27: Shaojing Hu and the shareholders listed in Boxes 30 and 31 are concert parties, each deemed interested in aggregate interests of 271,250,475 Shares, including the Shares owned by Wordspharma Ltd, which is wholly owned by Zhu Shen, Yinxiang Wang's wife.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 20/01/2022
(dd/mm/yyyy)